“Data is the new oil, but it is only valuable if it's refined. Recent advances in science and technology mean vast amounts of patient data are being generated on a daily basis, and you need artificial intelligence and machine learning to cope with it and make sense of it.
Bond Digital Health’s co-founder and CEO Ian Bond has been nominated for a prestigious national award. Ian is one of three finalists in the Innovation, Science & Technology award at the St David Awards 2019. Watch the video by clicking on 'read more’ below.
Every January tens of thousands of technology fans from across the world flock to the bright lights of Las Vegas for the annual Consumer Electronics Show (CES). Some of the biggest digital health and MedTech announcements of the year are made at CES and this year’s show was no exception, with wearable health tech products particularly popular.
At Bond Digital Health we believe the future of lateral flow is digital and we see it as our mission to help the sector fully realise the huge potential of this technology. Bond’s innovative 'software for medical devices supports POC assay developers and lateral flow reader manufactures by providing a digital platform for test data to be collected, analysed and displayed.
We are now moving into a new generation of lateral flow tests, one in which data is an integral part, and that is why we believe Bond Digital Health is perfectly placed to become a key player in the market; our technology enhances lateral flow tests transforming them into digitally connected assays that are part of a larger ecosystem improving decision making at the point-of-care.